Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

von Kaymakcalan, Zehra
Veröffentlicht in: Clinical immunology (Orlando, Fla.) (2009)